US 9650342
Compositions and methods of treating retinal disease
granted A61KA61K31/41A61K31/423
Quick answer
US patent 9650342 (Compositions and methods of treating retinal disease) held by Aldeyra Therapeutics, Inc. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/41, A61K31/423, A61K31/426, A61K31/435